Partial splenic embolization for the treatment of hypersplenism in cirrhotic HIV/HCV patients prior to pegylated interferon and ribavirin

Antiviral Therapy

Volumn 9, Issue 6, 2004, Pages 1027-1030

  Moreno, Ana ^a   Bárcena, Rafael ^a   Blázquez, Javier ^a   Quereda, Carmen ^a   Gil Grande, Luis ^a   Sánchez, Juan ^a   Moreno, Leonor ^a   Perez Elías, María J ^a   Antela, Antonio ^a   Moreno, Javier ^a   Del Campo, Santos ^a   Moreno, Santiago ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; PEGINTERFERON ALPHA2B; POLYVINYL ALCOHOL; RIBAVIRIN;

ADULT; AIDS RELATED COMPLEX; ARTICLE; CASE REPORT; CHEMOEMBOLIZATION; CHILD PUGH CLASSIFICATION; COMBINATION CHEMOTHERAPY; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERSPLENISM; INFECTIOUS COMPLICATION; INFECTIOUS HEPATITIS; LEUKOCYTE COUNT; LEUKOPENIA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; MALE; MIXED INFECTION; PARTIAL SPLENIC EMBOLIZATION; PRIORITY JOURNAL; SPLEEN INFARCTION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS TYPING;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; HYPERSPLENISM; INTERFERON ALFA-2A; INTERFERON ALFA-2B; LIVER CIRRHOSIS; MALE; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME;

EID: 19944379450     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R & Snydman DR. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases 2001; 32:492-497.
2. Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C & Poynard T. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatoiogy 1999; 30:1054-1058.
3. Perrone C, Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel F & ANRS HC02-RIBAVIC study group. Final results of ANRS HC02-RIBAVIC: a randomized controlled trial of pegylated-interferon-α-2b plus ribavirin for the initial treatment of chronic hepatitis C in HIV co-infected patients. 11th Conference on Retroviruses & Opportunistic Infections. 8-11 February 2004, San Francisco, Calif., USA. Abstract 117LB.
4. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, Lazzarin A, Carosi G, Sasadeusz J, Katlama C, Montaner J, Sette H Jr, Passe S, De Pamphilis J, Duff F, Schrenk UM & Dieterich DT; APRICOT Study Group. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. New England Journal of Medicine 2004; 351:438-450.
5. Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002; 36(Suppl 1):S237-S244.
6. McCormick PA & Murphy KM. Splenomegaly, hyperesplenism and coagulation abnormalities in liver disease. Bailliere's Clinical Gastroenterology 2000; 14:1009-1031.
7. Maddison FE. Embolic therapy of hyperesplenism. Investigative Radiology 1973; 8:280-281.
8. Sangro B, Bilbao I, Herrero I, Corella C, Longo J, Beloqui O, Ruiz J, Zozaya JM, Quiroga J & Prieto J. Partial splenic embolization for the treatment of hyperesplenism in cirrhosis. Hepatology 1993; 18:309-314.
9. Tajiri T, Onda M, Yoshida H, Mamada Y, Taniai N & Kumazaki T. Long-term hematological and biochemical effects of partial splenic embolization in hepatic cirrhosis. Hepato-gastroenterology 2002; 49:1445-1448.
10. Corti ME, Villafane MF, Suarez Anzorena F, Daruich J, Perez Bianco R, Candela M, Ferraina P & Tezanos Pinto M. [Splenic artery embolization for the treatment of hyperesplenism in hemophilic, HIV-1 and HCV seropositive patients]. Medicina (B Aires) 2003; 63:224-226. Spanish.
11. El-Kishen MA, Henderson JM, Millikan WJ Jr, Kutner MH & Warren WD. Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Quarterly Review of Surgery, Obstetrics & Gynecology 1985; 160:233-238.
12. Noguchi H, Hirai K, Aoki Y, Sakata K & Tanikawa K. Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology 1995; 22:1682-1688.
13. Hidaka H, Kokubu S, Saigenji K, Isobe Y & Maeda T. Restoration of thrombopoietin production after partial splenic embolization leads to resolution of thrombocytopenia in liver cirrhosis. Hepatological Research 2002; 23:265-273.
14. Vujic B & Lauver JW. Severe complication from partial splenic embolization in patients with liver failure. British Journal of Radiology 1981; 54:492-495.
15. Sakai T, Shiraki K, Inoue H, Sugimoto K, Ohmori S, Murata K, Tak K & Nakano T. Complications of partial splenic embolization in cirrhotic patients. Digestive Diseases & Sciences 2002; 47:388-391.